Understanding — Hemp, Cannabis & The Plant
Cannabinoid Profiles: How Genetics and Growing Conditions Shape the Plant
Two hemp plants grown from different seeds or in different conditions can produce very different cannabinoid profiles — here's why that happens and what it means for consistency.
Two hemp plants of the same species, grown in different conditions or from different seed stock, can produce meaningfully different cannabinoid profiles at harvest. Understanding why requires holding two things simultaneously: genetics sets the direction and ceiling of a plant's cannabinoid expression, and environment modulates that expression within the range genetics permits.
Neither factor alone determines what ends up in a finished preparation. Both matter, and their interaction is what makes cultivar selection and cultivation discipline inseparable from preparation quality.
The Enzymatic Foundation
Cannabinoid synthesis in hemp begins with a single precursor compound: cannabigerolic acid, or CBGA. Every cannabinoid the plant produces — THCA, CBDA, CBCA, and CBGA itself — originates from this molecule. The direction CBGA takes through the plant's biosynthetic pathway depends on which enzymes are expressed and in what quantities. THCA synthase converts CBGA toward THCA. CBDA synthase converts it toward CBDA. CBCA synthase converts it toward CBCA. CBGA that is not converted by any of these enzymes remains as CBGA — which decarboxylates to CBG.
The relative activity of these synthase enzymes is primarily genetically determined. A cultivar bred for high CBD expression carries genetic programming that favors CBDA synthase activity. A cultivar bred for CBG expression either carries reduced synthase activity across all three conversion pathways, or is harvested at an early developmental stage before conversion is complete — because CBGA concentrations are highest in young, pre-flowering plant material and decline as the plant matures and converts CBGA forward into other cannabinoids.
Why CBG cultivar development required deliberate breeding
In most mature hemp plants, CBG represents only a fraction of total cannabinoid content — typically under 1% — because most of the plant's CBGA has already been converted to CBDA or THCA by the time flowers mature. Producing commercially useful CBG concentrations required either early-harvest protocols that catch CBGA before conversion, or selective breeding for plants that express reduced synthase activity, preserving more CBGA as CBG. The CBG cultivars used in current research and production are the result of that breeding work, which accelerated significantly after the 2018 Farm Bill opened the door for legal hemp cultivation and investment.
Genetics: What Cultivar Selection Determines
A cultivar — a cultivated variety selected and maintained for consistent expression of specific traits — is the primary unit of genetic decision-making in hemp production. Selecting a cultivar means selecting the genetic program the plant will run: which cannabinoids will be expressed, in what approximate ratios, and within what range of total cannabinoid concentration. Feminized seed stock from a well-characterized cultivar carries that genetic program reliably from plant to plant within a batch, which is the foundation of batch-to-batch consistency in finished preparations.
Environment: What Growing Conditions Modulate
Within the range a cultivar's genetics establish, environmental conditions shape the plant's actual expression at harvest. Genetics determines which cannabinoids are possible and in what approximate proportions; environment influences how fully that potential is realized.
Primary Determinant
Genetics
Sets the ceiling and direction of cannabinoid expression. Determines which synthase enzymes are present and in what relative activity. Establishes the cannabinoid profile type — CBD-dominant, CBG-dominant, and so on. Consistent across plants of the same cultivar grown from the same seed stock.
Controls: which cannabinoids, in what ratios
Modulating Factor
Environment
Soil nutrition, light intensity and duration, temperature range, water availability, and plant stress all influence how fully the plant's genetic potential is expressed. A well-supported plant in biologically active soil typically expresses more completely than the same cultivar grown under nutritional or environmental stress.
Modulates: total expression within genetic range
Light intensity and photoperiod influence terpene production alongside cannabinoid development — terpenes are synthesized in the same trichome structures as cannabinoids and respond to similar environmental signals. Mild, controlled stress during the flowering period has been observed to increase resin production in some cultivars, likely as a plant defense response. Water stress at the wrong stage can suppress cannabinoid development. Soil nutrition — particularly the availability of nitrogen, phosphorus, and trace minerals during key developmental phases — supports the enzymatic activity that drives secondary compound synthesis.
These variables interact with each other and with the plant's genetic program in ways that are not fully characterized in the literature. What is clear is that the same cultivar grown under meaningfully different conditions can produce measurably different cannabinoid concentrations at harvest — not different profiles, since genetics determines the profile type, but different total expression within that type.
Terpenes: The Other Dimension of the Plant's Profile
Cannabinoid concentration is one dimension of a hemp plant's chemical profile. Terpenes are the other. These volatile aromatic compounds — myrcene, limonene, pinene, linalool, and dozens of others — are synthesized in the same trichomes as cannabinoids and contribute to the distinctive aromatic character of each cultivar. Terpene expression is both genetically influenced and environmentally sensitive, with temperature and light exposure during the flowering phase having measurable effects on terpene concentration and composition at harvest.
In a full-spectrum preparation, the terpene profile is carried alongside the cannabinoid profile through extraction — which is one reason extraction method and handling temperature matter for what the finished preparation contains. The terpenes that distinguish one cultivar's aromatic character from another's are present in the plant in relatively small concentrations and are the first compounds to degrade under heat, oxidation, or careless handling.
The cannabinoid profile in a finished hemp preparation is the end point of a chain that begins with cultivar genetics and runs through every cultivation and handling decision that follows. Understanding that chain explains why two preparations both accurately labeled "full-spectrum CBD" can differ in composition, and why cultivar selection and growing conditions are as much a part of preparation quality as extraction method or laboratory testing. The chemistry visible in a COA reflects the biology of the plant — and the biology of the plant reflects the decisions made before harvest.
References
- Hazekamp, A., & Fischedick, J.T. (2012). Cannabis — from cultivar to chemovar. Drug Testing and Analysis, 4(7–8), 660–667.
- Taura, F., Morimoto, S., & Shoyama, Y. (1996). Purification and characterization of cannabidiolic-acid synthase from Cannabis sativa L. Journal of Biological Chemistry, 271(29), 17411–17416.
- Fischedick, J.T., Hazekamp, A., Erkelens, T., Choi, Y.H., & Verpoorte, R. (2010). Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry, 71(17–18), 2058–2073.
- Andre, C.M., Hausman, J.F., & Guerriero, G. (2016). Cannabis sativa: the plant of the thousand and one molecules. Frontiers in Plant Science, 7, 19.
- Aizpurua-Olaizola, O., Soydaner, U., Öztürk, E., et al. (2016). Evolution of the cannabinoid and terpene content during the growth of Cannabis sativa plants from different chemotypes. Journal of Natural Products, 79(2), 324–331.
These statements have not been evaluated by the Food and Drug Administration. J.P. Hemp Company products are not intended to diagnose, treat, cure, or prevent any disease.